Botulinum toxin blocks mast cells and prevents rosacea like inflammation

Jae Eun Choi1, Tyler Werbel2, Zhenping Wang1

  • 1Department of Dermatology, University of California, San Diego, CA, USA.

Abstract

Insights

Onabotulinum toxin (Botox) directly inhibits mast cell degranulation, a key factor in rosacea. This finding supports Botox as a potential therapy for severe rosacea.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Rosacea is a chronic inflammatory skin condition.
  • Mast cells and cathelicidin LL-37 are implicated in rosacea etiology.
  • Onabotulinum toxin shows clinical benefit in refractory rosacea, but its mechanism is unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism of onabotulinum toxin in improving rosacea lesions.
  • To investigate the direct effects of onabotulinum toxin on mast cells.

Main Methods:

  • Human and murine mast cells were treated with onabotulinum toxin A or B.
  • Mast cell degranulation was assessed via beta-hexosaminidase activity.
  • In vivo rosacea models were established using LL-37 and onabotulinum toxin A.
  • Expression of botulinum toxin receptor Sv2, SNAP-25, and VAMP2 was analyzed.

Main Results:

  • Onabotulinum toxin A and B inhibited mast cell degranulation in vitro.
  • Onabotulinum toxin A and B altered SNAP-25 and VAMP2 expression in mast cells.
  • In vivo, onabotulinum toxin A reduced LL-37-induced erythema, mast cell degranulation, and rosacea biomarkers.

Conclusions:

  • Onabotulinum toxin directly inhibits mast cell degranulation, reducing rosacea inflammation.
  • Onabotulinum toxin may be an effective treatment for refractory rosacea.
  • Further research into onabotulinum toxin for rosacea is warranted.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.2K
Inflammation01:38

Inflammation

Overview
62.0K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.8K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
554